Clinical trial
A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced…
NCT00121628 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00121628 |
|---|---|
| Title | A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer |
| Official title | A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Thyroid Cancer |
| Intervention type | Drug |
| Interventions | AMG 706 |
| Enrollment | 184 |
| Start date | Jul 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Oct 1, 2010 |
| First posted | Jul 21, 2005 |
| Last update posted | Oct 9, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: